Fospropofol Intravenous and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Fospropofol Intravenous and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fospropofol
Brand name:
Synonyms: Fospropofol (Intravenous)
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fospropofol Intravenous-Insulin glulisine
- Fospropofol Intravenous-Insulin Glulisine (Cartridges and Pens)
- Fospropofol Intravenous-Insulin Glulisine (Vials)
- Fospropofol Intravenous-Insulin glulisine Subcutaneous
- Fospropofol Intravenous-Insulin human inhaled Inhalation
- Fospropofol Intravenous-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Fosrenol
- Insulin glargine, recombinant Subcutaneous-Fosrenol (Lanthanum Chewable Tablets)
- Insulin glargine, recombinant Subcutaneous-Fosrenol (Lanthanum Powder)
- Insulin glargine, recombinant Subcutaneous-Fostamatinib
- Insulin glargine, recombinant Subcutaneous-Fostamatinib disodium
- Insulin glargine, recombinant Subcutaneous-Fosteum